Comparison of drug eluting stents (DESs) and bare metal stents (BMSs) with STEMI: who received BMS in the era of 2nd generation DES?

Previous studies have indicated that drug eluting stents (DESs) are associated with better outcomes than bare metal stents (BMSs); however, a debate exists among physicians when selecting the optimal stent for certain high-risk patients.1 –3 The early successes of 1st generation DESs over BMSs have been curtailed by frequently encountered long term adverse events, which often result in hypersensitivity reactions associated with the polymer coating or delayed stent endothelialization.4 The usage of BMSs has continuously declined fol lowing the initial approval of 2nd generation DESs.

Source: Heart and Lung - March 12, 2018 Category: Intensive Care Authors: Rajkumar Doshi, Jay Shah, Varun Jauhar, Dean Decter, Rajiv Jauhar, Perwaiz Meraj Source Type: research